New Data, Tools, and Insights on Using Antiarrhythmic Drugs in Atrial Fibrillation Management

This satellite symposium examines the latest data and recommendations for antiarrhythmic drugs in managing atrial fibrillation in the post-CABANA era.

Live Meeting

2.00 available credits

Information

April 29, 2022

11:45 AM - 01:45 PM PDT

InterContinental San Francisco
Grand Ballroom A & B - 3rd Floor, 888 Howard Street, San Francisco, California, United States

Details

Presenters

Comments

Overview
This live satellite symposium describes the variety of antiarrhythmic drugs that are available and presents the rationale for using them to manage atrial fibrillation. This clinician-oriented program focuses on both inpatient and outpatient care. Issues such as which drug class to use, the adverse effects (QT prolongation), drug-drug interactions, organ toxicity, tradeoffs, cost, effect on length of hospital stay, and how and when to use IV antiarrhythmic drugs will be highlighted.
This program is not part of the 2022 Heart Rhythm Scientific Sessions as planned by the Scientific Sessions Program Committee.
This event is neither sponsored nor endorsed by the Heart Rhythm Society.

Program Schedule*

11:45 am–12:00 pm	Registration and Lunch

12:00 pm–12:05 pm	Welcome, Introductions, Program Overview T. Jared Bunch, MD Dhanunjaya “DJ” Lakkireddy, MD Program Chairs

12:05 pm–12:25 pm 12:25 pm-12:35 pm	Antiarrhythmic Drugs in the Management of Atrial Fibrillation Bradley P. Knight, MD Case Presentation Followed by Panel Discussion Ben Steinberg, MD All Faculty
12:35 pm–12:55 pm 12:55 pm-1:05 pm	Considerations on Using Antiarrhythmics When Providing Inpatient or Outpatient Care T. Jared Bunch, MD Case Presentation Followed by Panel Discussion Ben Steinberg, MD and Faculty

1:05 pm–1:25 pm	Is There a Role for Antiarrhythmic Drugs in the Era of Catheter Ablation? Dhanunjaya “DJ” Lakkireddy, MD

1:25 pm–1:35 pm	Case Presentation with Panel Discussion Ben Steinberg, MD All Faculty

1:35 pm–1:45 pm	Q&A moderated by Co-Chairs All Faculty


*Subject to change

Disclosure of Conflicts of Interest
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Program Chairs:
T. Jared Bunch, MD
Professor of Medicine
University of Utah School of Medicine
Salt Lake City, UT
Dhanunjaya “DJ” Lakkireddy, MD
Medical Director, Kansas City Heart Rhythm Institute
HCA Midwest Health
Overland Park, KS
Faculty:
Bradley P. Knight, MD
Director, Cardiac Electrophysiology at Northwestern Medicine
Director, Heart Rhythm Center at the Bluhm Cardiovascular Institute
Chester C. and Deborah M. Cooley Distinguished Professor of Cardiology
Professor of Medicine (Cardiology) and Medical Education
Northwestern Feinberg School of Medicine
Chicago, IL
Benjamin A. Steinberg, MD, MHS, FACC, FHRS
Associate Professor of Medicine
Cardiovascular Medicine Division
University of Utah
Salt Lake City, UT
Reviewers/Content Planners/Authors:
- Sean T. Barrett has nothing to disclose.
- Ben Caref, PhD, has nothing to disclose.
- Cindy Davidson has nothing to disclose.
- Kate Nagele has nothing to disclose.
- Kathy Wickman, BSN, has nothing to disclose.
Learning Objectives
After participating in this educational activity, participants should be better able to:
- Recognize the clinical consequences of atrial fibrillation (AF) including the impact of AF on hospitalizations and healthcare resources
- Explain the importance of making sinus rhythm an important achievable goal in specific patient subgroups through the use of antiarrhythmic drug therapies
- Describe the antiarrhythmic drug classes for use in AF cardioversion
- Describe clinical algorithms for selecting antiarrhythmic drugs based on patient and drug characteristics
- Explain how to convert IV formulations of an antiarrhythmic drug used in AF cardioversion into oral therapy once sinus rhythm has been achieved
Target Audience
This activity is designed to meet the educational needs of electrophysiologists.
Accreditation and Credit Designation Statements
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Global Learning Collaborative (GLC) designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 120-minutes of nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Provider(s)/Educational Partner(s)
Our ultimate goal is to improve the care being delivered to patients, and our high quality, evidence-based CME initiatives reflect our dedication to the creation and execution of excellence and are the product of shared research, knowledge, and clinical practice skills across the healthcare continuum.
Commercial Support
This activity is supported by an independent educational grant from AltaThera Pharmaceuticals.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Medtelligence. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Medtelligence you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.
ADA Statement
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Kate Nagele prior to the live event at knagele@glc.healthcare.

Presenters

T. Jared Bunch, MD

Dhanunjaya “DJ” Lakkireddy, MD

Bradley P. Knight, MD

Benjamin Steinberg, MD

Facebook Comments

Details

Presenters

Comments

Overview
This live satellite symposium describes the variety of antiarrhythmic drugs that are available and presents the rationale for using them to manage atrial fibrillation. This clinician-oriented program focuses on both inpatient and outpatient care. Issues such as which drug class to use, the adverse effects (QT prolongation), drug-drug interactions, organ toxicity, tradeoffs, cost, effect on length of hospital stay, and how and when to use IV antiarrhythmic drugs will be highlighted.
This program is not part of the 2022 Heart Rhythm Scientific Sessions as planned by the Scientific Sessions Program Committee.
This event is neither sponsored nor endorsed by the Heart Rhythm Society.

Program Schedule*

11:45 am–12:00 pm	Registration and Lunch

12:00 pm–12:05 pm	Welcome, Introductions, Program Overview T. Jared Bunch, MD Dhanunjaya “DJ” Lakkireddy, MD Program Chairs

12:05 pm–12:25 pm 12:25 pm-12:35 pm	Antiarrhythmic Drugs in the Management of Atrial Fibrillation Bradley P. Knight, MD Case Presentation Followed by Panel Discussion Ben Steinberg, MD All Faculty
12:35 pm–12:55 pm 12:55 pm-1:05 pm	Considerations on Using Antiarrhythmics When Providing Inpatient or Outpatient Care T. Jared Bunch, MD Case Presentation Followed by Panel Discussion Ben Steinberg, MD and Faculty

1:05 pm–1:25 pm	Is There a Role for Antiarrhythmic Drugs in the Era of Catheter Ablation? Dhanunjaya “DJ” Lakkireddy, MD

1:25 pm–1:35 pm	Case Presentation with Panel Discussion Ben Steinberg, MD All Faculty

1:35 pm–1:45 pm	Q&A moderated by Co-Chairs All Faculty


*Subject to change

Disclosure of Conflicts of Interest
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Program Chairs:
T. Jared Bunch, MD
Professor of Medicine
University of Utah School of Medicine
Salt Lake City, UT
Dhanunjaya “DJ” Lakkireddy, MD
Medical Director, Kansas City Heart Rhythm Institute
HCA Midwest Health
Overland Park, KS
Faculty:
Bradley P. Knight, MD
Director, Cardiac Electrophysiology at Northwestern Medicine
Director, Heart Rhythm Center at the Bluhm Cardiovascular Institute
Chester C. and Deborah M. Cooley Distinguished Professor of Cardiology
Professor of Medicine (Cardiology) and Medical Education
Northwestern Feinberg School of Medicine
Chicago, IL
Benjamin A. Steinberg, MD, MHS, FACC, FHRS
Associate Professor of Medicine
Cardiovascular Medicine Division
University of Utah
Salt Lake City, UT
Reviewers/Content Planners/Authors:
- Sean T. Barrett has nothing to disclose.
- Ben Caref, PhD, has nothing to disclose.
- Cindy Davidson has nothing to disclose.
- Kate Nagele has nothing to disclose.
- Kathy Wickman, BSN, has nothing to disclose.
Learning Objectives
After participating in this educational activity, participants should be better able to:
- Recognize the clinical consequences of atrial fibrillation (AF) including the impact of AF on hospitalizations and healthcare resources
- Explain the importance of making sinus rhythm an important achievable goal in specific patient subgroups through the use of antiarrhythmic drug therapies
- Describe the antiarrhythmic drug classes for use in AF cardioversion
- Describe clinical algorithms for selecting antiarrhythmic drugs based on patient and drug characteristics
- Explain how to convert IV formulations of an antiarrhythmic drug used in AF cardioversion into oral therapy once sinus rhythm has been achieved
Target Audience
This activity is designed to meet the educational needs of electrophysiologists.
Accreditation and Credit Designation Statements
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Global Learning Collaborative (GLC) designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 120-minutes of nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Provider(s)/Educational Partner(s)
Our ultimate goal is to improve the care being delivered to patients, and our high quality, evidence-based CME initiatives reflect our dedication to the creation and execution of excellence and are the product of shared research, knowledge, and clinical practice skills across the healthcare continuum.
Commercial Support
This activity is supported by an independent educational grant from AltaThera Pharmaceuticals.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Medtelligence. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Medtelligence you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.
ADA Statement
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Kate Nagele prior to the live event at knagele@glc.healthcare.

Presenters

T. Jared Bunch, MD

Dhanunjaya “DJ” Lakkireddy, MD

Bradley P. Knight, MD

Benjamin Steinberg, MD

New Data, Tools, and Insights on Using Antiarrhythmic Drugs in Atrial Fibrillation Management

Program Schedule*

Disclosure of Conflicts of Interest

Learning Objectives

Target Audience

Accreditation and Credit Designation Statements

Provider(s)/Educational Partner(s)

Commercial Support

Disclaimer

ADA Statement

Facebook Comments

Program Schedule*

Disclosure of Conflicts of Interest

Learning Objectives

Target Audience

Accreditation and Credit Designation Statements

Provider(s)/Educational Partner(s)

Commercial Support

Disclaimer

ADA Statement

Facebook Comments

NEED HELP?

Contact us

NEED HELP?

Contact us

Facebook Comments

Facebook Comments

Title

NEED HELP?

Contact us

Share on ReachMD

Get a Dose of Medtelligence in Your Inbox and Practice Smarter Medicine